5 443

Cited 0 times in

Association between serum thymosin β4 levels of rheumatoid arthritis patients and disease activity and response to therapy.

Authors
 Ran Song  ;  Hyun Mi Choi  ;  Hyung-In Yang  ;  Myung Chul Yoo  ;  Yong-Beom Park  ;  Kyoung Soo Kim 
Citation
 CLINICAL RHEUMATOLOGY, Vol.31(8) : 1253-1258, 2012 
Journal Title
CLINICAL RHEUMATOLOGY
ISSN
 0770-3198 
Issue Date
2012
MeSH
Adult ; Antirheumatic Agents/therapeutic use* ; Arthritis, Rheumatoid/blood* ; Arthritis, Rheumatoid/drug therapy ; Drug Resistance ; Drug Therapy, Combination ; Enzyme-Linked Immunosorbent Assay ; Female ; Humans ; Male ; Middle Aged ; Severity of Illness Index ; Thymosin/blood* ; Tumor Necrosis Factor-alpha/antagonists & inhibitors ; Tumor Necrosis Factor-alpha/therapeutic use*
Keywords
Disease-modifying antirheumatic drugs (DMARDs) ; Rheumatoid arthritis (RA) ; Thymosin β4 (Tβ4) ; Tumor necrosis factor (TNF)-α blocker
Abstract
The aim of this study was to evaluate whether thymosin β4 (Tβ4) levels are increased in the serum of rheumatoid arthritis (RA) patients, and if this increase is associated with RA disease activity and resistance to treatment. Blood samples from 40 patients with RA were collected at baseline and 6 months after starting treatment with disease-modifying antirheumatic drugs (DMARD) and/or tumor necrosis factor (TNF)-α blocker. Serum levels of Tβ4 were measured by ELISA. Tβ4 levels (mean ± standard deviation) in RA patients were significantly (approximately tenfold) higher than in healthy controls (577.4 ± 67.92 vs. 56.61 ± 5.72 ng/mL). Serum Tβ4 levels in patients with severe disease activity before therapy were slightly higher than in patients with moderate disease activity (662.4 ± 491.5 vs. 462.5 ± 305.3 ng/ml, P > 0.05). Tβ4 levels were significantly associated with disease activity according to the 28-joint Disease Activity Score. The mean Tβ4 level at baseline in the DMARD treatment group was significantly lower than in the DMARD + TNF-α blocker treatment group. Tβ4 levels were increased in the serum of patients with RA and were positively associated with disease activity. Levels of Tβ4 may also be relevant in determining or predicting resistance to RA treatment. Further studies are necessary to determine if Tβ4 is an appropriate therapeutic target for controlling inflammation associated with RA.
Full Text
http://link.springer.com/article/10.1007%2Fs10067-012-2011-7
DOI
22653616
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
Yonsei Authors
Park, Yong Beom(박용범)
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/90049
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links